WB
ARQT icon

WesBanco Bank’s Arcutis Biotherapeutics ARQT Stock Holding History

WesBanco Bank’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Buy
81,100
+32,600
+67% +$759K 0.05% 252
2026
Q1 		$1.14M Hold
48,500
– – 0.03% 351
2025
Q4 		$1.41M Sell
48,500
-23,200
-32% -$594K 0.04% 306
2025
Q3 		$1.35M Sell
71,700
-31,000
-30% -$489K 0.04% 322
2025
Q2 		$1.44M Hold
102,700
– – 0.04% 292
2025
Q1 		$1.61M Hold
102,700
– – 0.06% 238
2024
Q4 		$1.43M Hold
102,700
– – 0.05% 264
2024
Q3 		$955K Buy
+102,700
New +$1.01M 0.03% 330

Other funds holding ARQT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

WesBanco Bank's ARQT Position: Q2 2026 in Review

WesBanco Bank increased its Arcutis Biotherapeutics (ARQT) stake by 67% in Q2 2026, buying an estimated $759K and bringing the position to 81,100 shares worth $2.13M. The position accounts for 0.05% of the portfolio, ranked #252.

WesBanco Bank first reported a position in ARQT in Q3 2024 and has held it in 8 quarters since. 273 funds tracked by Wall St. Rank hold ARQT as of Q2 2026.

  • WesBanco Bank held 81,100 shares of Arcutis Biotherapeutics worth $2.13M as of Q2 2026.
  • WesBanco Bank bought 32,600 Arcutis Biotherapeutics shares in Q2 2026, an estimated $759K.
  • Arcutis Biotherapeutics made up 0.05% of WesBanco Bank's portfolio in Q2 2026, its #252 holding.
  • WesBanco Bank first reported a position in Arcutis Biotherapeutics in Q3 2024 and has held it in 8 quarters since.
  • 273 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.